Clinical Trial Update: A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and seroconversion with Sabin inactivated poliovirus vaccine schedules in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED